Asia Pacific blood culture tests market will grow by 9.7% annually with a total addressable market cap of $16.74 billion over 2022-2031 owing to the rising prevalence of bloodstream infections, increasing number of sepsis cases and high cost of treatment, rising geriatric population, and the rising demand for rapid diagnostic techniques amid the COVID-19 pandemic.
Highlighted with 32 tables and 54 figures, this 110-page report “Asia Pacific Blood Culture Tests Market 2021-2031 by Product (Consumables, Instruments, Software and Services), Method (Conventional, Automated), Technology (Culture-Based, Molecular, Proteomics, Others), Application (Bacteremia, Fungemia, Mycobacterial Detection), End User (Hospital Laboratories, Reference Laboratories, Academic Research Laboratories), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific blood culture tests market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific blood culture tests market in every aspect of the classification from perspectives of Product, Method, Technology, Application, End User, and Country.
Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Consumables
o Blood Culture Media
o Assay Kits & Reagents
o Blood Culture Accessories
• Instruments
o Automated Blood Culture Systems
o Supporting Laboratory Equipment
• Software and Services
Based on Method, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Conventional/Manual Methods
• Automated Methods
Based on Technology, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Culture-Based Technologies
• Molecular Technologies
o Microarrays
o Polymerase Chain Reaction (PCR)
o PNA-FISH
• Proteomics Technology
• Other Technologies
Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Bacteremia
• Fungemia
• Mycobacterial Detection
Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Hospital Laboratories
• Reference Laboratories
• Academic Research Laboratories
• Other End Users
Geographically, the following national/local markets are fully investigated:
• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of the regional market by country and split of key national markets by Product, Application, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Autobio Diagnostics Co., Ltd.
Becton, Dickinson and Company (BD)
Binder Gmbh
Biobase Biotech (Jinan) Co., Ltd.
BioMérieux SA
Bruker Corporation
Carl Zeiss Ag
Cepheid Inc. (Danaher Corporation)
F. Hoffmann-La Roche Ltd.
Luminex Corporation
Neogen Corporation (Abtek Biologicals)
OpGen Inc.
T2 Biosystems, Inc.
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 22
2.2 Major Growth Drivers 24
2.3 Market Restraints and Challenges 29
2.4 Emerging Opportunities and Market Trends 32
2.5 Porter’s Fiver Forces Analysis 36
3 Segmentation of Asia Pacific Market by Product 40
3.1 Market Overview by Product 40
3.2 Consumables 42
3.2.1 Blood Culture Media 44
3.2.2 Assay Kits & Reagents 45
3.2.3 Blood Culture Accessories 46
3.3 Instruments 47
3.3.1 Automated Blood Culture Systems 48
3.3.2 Supporting Laboratory Equipment 49
3.4 Software and Services 50
4 Segmentation of Asia Pacific Market by Method 51
4.1 Market Overview by Method 51
4.2 Conventional/Manual Methods 53
4.3 Automated Methods 54
5 Segmentation of Asia Pacific Market by Technology 55
5.1 Market Overview by Technology 55
5.2 Culture-Based Technologies 57
5.3 Molecular Technologies 58
5.3.1 Microarrays 59
5.3.2 Polymerase Chain Reaction (PCR) 60
5.3.3 PNA-FISH 61
5.4 Proteomics Technology 62
5.5 Other Technologies 63
6 Segmentation of Asia Pacific Market by Application 64
6.1 Market Overview by Application 64
6.2 Bacteremia 66
6.3 Fungemia 67
6.4 Mycobacterial Detection 68
7 Segmentation of Asia Pacific Market by End User 69
7.1 Market Overview by End User 69
7.2 Hospital Laboratories 71
7.3 Reference Laboratories 72
7.4 Academic Research Laboratories 73
7.5 Other End Users 74
8 Asia-Pacific Market 2021-2031 by Country 75
8.1 Overview of Asia-Pacific Market 75
8.2 Japan 78
8.3 China 81
8.4 Australia 83
8.5 India 85
8.6 South Korea 87
8.7 Rest of APAC Region 89
9 Competitive Landscape 91
9.1 Overview of Key Vendors 91
9.2 New Product Launch, Partnership, Investment, and M&A 94
9.3 Company Profiles 95
Autobio Diagnostics Co., Ltd. 95
Becton, Dickinson and Company (BD) 97
Binder Gmbh 98
Biobase Biotech (Jinan) Co., Ltd. 99
BioMérieux SA 100
Bruker Corporation 101
Carl Zeiss Ag 102
Cepheid Inc. (Danaher Corporation) 103
F. Hoffmann-La Roche Ltd. 104
Luminex Corporation 105
Neogen Corporation (Abtek Biologicals) 106
OpGen Inc. 107
T2 Biosystems, Inc. 108
Thermo Fisher Scientific Inc. 109
RELATED REPORTS 110
List of Tables:
Table 1. Snapshot of Asia Pacific Blood Culture Tests Market in Balanced Perspective, 2021-2031 17
Table 2. World Economic Outlook, 2021-2031 21
Table 3. World Health Spending by Region, $ bn, 2013-2020 28
Table 4. Main Product Trends and Market Opportunities in Asia Pacific Blood Culture Tests Market 32
Table 5. Asia Pacific Blood Culture Tests Market by Product, 2021-2031, $ mn 40
Table 6. Asia Pacific Blood Culture Tests Market: Consumables by Type, 2021-2031, $ mn 42
Table 7. Asia Pacific Blood Culture Tests Market: Instruments by Type, 2021-2031, $ mn 47
Table 8. Asia Pacific Blood Culture Tests Market by Method, 2021-2031, $ mn 51
Table 9. Asia Pacific Blood Culture Tests Market by Technology, 2021-2031, $ mn 55
Table 10. Asia Pacific Blood Culture Tests Market: Molecular Technologies by Type, 2021-2031, $ mn 58
Table 11. Asia Pacific Blood Culture Tests Market by Application, 2021-2031, $ mn 64
Table 12. Asia Pacific Blood Culture Tests Market by End User, 2021-2031, $ mn 69
Table 13. APAC Blood Culture Tests Market by Country, 2021-2031, $ mn 76
Table 14. Japan Blood Culture Tests Market by Product, 2021-2031, $ mn 80
Table 15. Japan Blood Culture Tests Market by Application, 2021-2031, $ mn 80
Table 16. Japan Blood Culture Tests Market by End User, 2021-2031, $ mn 80
Table 17. China Blood Culture Tests Market by Product, 2021-2031, $ mn 82
Table 18. China Blood Culture Tests Market by Application, 2021-2031, $ mn 82
Table 19. China Blood Culture Tests Market by End User, 2021-2031, $ mn 82
Table 20. Australia Blood Culture Tests Market by Product, 2021-2031, $ mn 84
Table 21. Australia Blood Culture Tests Market by Application, 2021-2031, $ mn 84
Table 22. Australia Blood Culture Tests Market by End User, 2021-2031, $ mn 84
Table 23. India Blood Culture Tests Market by Product, 2021-2031, $ mn 86
Table 24. India Blood Culture Tests Market by Application, 2021-2031, $ mn 86
Table 25. India Blood Culture Tests Market by End User, 2021-2031, $ mn 86
Table 26. South Korea Blood Culture Tests Market by Product, 2021-2031, $ mn 88
Table 27. South Korea Blood Culture Tests Market by Application, 2021-2031, $ mn 88
Table 28. South Korea Blood Culture Tests Market by End User, 2021-2031, $ mn 88
Table 29. Blood Culture Tests Market in Rest of APAC by Country/Region, 2021-2031, $ mn 90
Table 30. Autobio Diagnostics Co., Ltd.: Company Snapshot 95
Table 31. Autobio Diagnostics Co., Ltd.: Business Segmentation 96
Table 32. Autobio Diagnostics Co., Ltd.: Product Portfolio 96
